Abstract:Immunonutrition is administered to improve the outcome of patients with pancreatic cancer undergoing surgery. However, its effect and mechanism of action remain unclear. Therefore, we conducted this systematic review and meta-analysis to assess its effects on postoperative outcome and the immune system. Randomized controlled trials (RCTs) were identified and data extracted by two reviewers independently from electronic databases from their inception to 31 October 2019. The result was expressed as the risk ratio (RR) for categorical variables and mean difference (MD) for continuous variables with 95% confidence intervals (CIs). Six RCTs published from 1999 and 2016, with a total of 368 patients, were included. The results revealed that immunonutrition significantly decreased the rate of infectious complications (RR = 0.47, 95% CI (0.23, 0.94), p = 0.03) and the length of hospital stay (MD = −1.90, 95% CI (−3.78, −0.02), p = 0.05) by modulating the immune system, especially in preoperative group in subgroup analysis. We therefore recommend that patients with pancreatic cancer undergoing surgery could take the advantage of immunonutrition, especially in the preoperative period.

What problem does this paper attempt to address?

The problem this paper attempts to address is the evaluation of the effects of immunonutrition on postoperative complications, hospital stay, and the immune system in patients undergoing surgery for pancreatic cancer. Specifically, the researchers aim to determine, through systematic review and meta-analysis, whether preoperative, intraoperative, or postoperative supplementation with immunonutrition can improve the clinical outcomes of these patients. ### Main Issues: 1. **Total Postoperative Complications**: Can immunonutrition reduce the incidence of total postoperative complications? 2. **Postoperative Infectious Complications**: Can immunonutrition reduce the incidence of postoperative infectious complications? 3. **Postoperative Non-infectious Complications**: Can immunonutrition reduce the incidence of postoperative non-infectious complications? 4. **Hospital Stay**: Can immunonutrition shorten the length of hospital stay? 5. **Postoperative Mortality**: Can immunonutrition reduce postoperative mortality? 6. **Impact on the Immune System**: Can immunonutrition improve the function of the immune system postoperatively? ### Research Background: - Pancreatic cancer is a highly lethal malignancy, and despite advances in diagnosis and treatment, the 5-year survival rate remains very low. - Surgery is the main treatment for resectable pancreatic cancer, but postoperative complications such as infections and non-infectious complications can affect patient recovery and quality of life. - Immunonutrition is a nutritional supplement containing immunomodulators such as arginine, ω-3 fatty acids, and RNA, which is believed to improve patients' immune status and postoperative recovery. ### Research Methods: - **Inclusion Criteria**: Randomized controlled trials (RCTs) involving patients with resectable pancreatic cancer undergoing surgery, with the intervention being preoperative, intraoperative, or postoperative oral immunonutrition supplements, and the control group receiving standard diet. - **Exclusion Criteria**: Studies involving other types of cancer, studies not comparing with standard diet, and animal experiments. - **Data Extraction**: Literature was screened from databases, data were independently extracted and cross-checked. - **Statistical Analysis**: Meta-analysis was performed using RevMan 5.3 software, with results expressed as risk ratios (RR) and mean differences (MD), and 95% confidence intervals (CIs) provided. ### Research Results: - **Total Postoperative Complications**: No significant difference. - **Postoperative Infectious Complications**: Preoperative use of immunonutrition significantly reduced the incidence of postoperative infectious complications. - **Postoperative Non-infectious Complications**: No significant difference. - **Hospital Stay**: Preoperative use of immunonutrition significantly shortened the length of hospital stay. - **Postoperative Mortality**: No significant difference. - **Impact on the Immune System**: No significant impact on CD4+ levels. ### Conclusion: - Preoperative use of immunonutrition can significantly reduce the incidence of postoperative infectious complications and shorten the length of hospital stay in patients with pancreatic cancer, thus it is recommended to use immunonutrition preoperatively.

Immunonutrition in Patients with Pancreatic Cancer Undergoing Surgical Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials